The Swiss Ypsomed Group starts construction of a new production facility
With more than 30 years of experience, the Ypsomed Group is the leading company in the production of injection and infusion systems. Pharmaceutical and biotechnology companies from around the world prefer the high-quality products from the innovation and technology leader from Switzerland. The Group has a global network and employs around 1,200 staff around the world. As the production facilities in Switzerland were operating at the limit of their capacity, Ypsomed decided to construct a further production plant in Europe. Amid tough competition Schwerin finally succeeded in carrying the day against locations in Switzerland and the Czech Republic.